ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 103 filers reported holding ADICET BIO INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,697 | -99.7% | 5,618 | -99.4% | 0.00% | -100.0% |
| Q2 2023 | $2,481,281 | +1271.3% | 1,021,103 | +3150.5% | 0.00% | – |
| Q1 2023 | $180,945 | -97.0% | 31,414 | -95.4% | 0.00% | -100.0% |
| Q4 2022 | $6,107,665 | -36.5% | 683,184 | +1.1% | 0.00% | -33.3% |
| Q3 2022 | $9,612,000 | -2.9% | 675,976 | -0.3% | 0.01% | 0.0% |
| Q2 2022 | $9,896,000 | -26.9% | 677,865 | +0.0% | 0.01% | 0.0% |
| Q1 2022 | $13,536,000 | +2623.5% | 677,810 | +2286.4% | 0.01% | – |
| Q4 2021 | $497,000 | +129.0% | 28,403 | +2.4% | 0.00% | – |
| Q3 2021 | $217,000 | +69.5% | 27,741 | +123.4% | 0.00% | – |
| Q2 2021 | $128,000 | – | 12,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,885,000 | 9.89% |
| Foresite Capital Management V, LLC | 680,000 | $9,928,000 | 6.94% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,482,000 | 6.26% |
| DAFNA Capital Management LLC | 935,766 | $13,662,000 | 3.72% |
| COWEN AND COMPANY, LLC | 2,443,780 | $35,679,000 | 3.45% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,468,000 | 3.21% |
| JOHNSON & JOHNSON | 728,944 | $10,643,000 | 2.72% |
| Cormorant Asset Management, LP | 1,800,000 | $26,280,000 | 1.99% |
| Orbimed Advisors | 7,447,141 | $108,728,000 | 1.97% |
| RTW INVESTMENTS, LP | 3,951,281 | $57,689,000 | 1.49% |